Market Cap 161.88M P/E - EPS this Y -33.30% Ern Qtrly Grth -
Income -105.09M Forward P/E -2.28 EPS next Y 48.60% 50D Avg Chg -73.00%
Sales 12.94M PEG -0.19 EPS past 5Y - 200D Avg Chg -76.00%
Dividend N/A Price/Book 1.24 EPS next 5Y 30.00% 52W High Chg -82.00%
Recommedations 1.40 Quick Ratio 4.40 Shares Outstanding 98.71M 52W Low Chg 9.00%
Insider Own 1.23% ROA -28.34% Shares Float 72.23M Beta 1.95
Inst Own 87.82% ROE -70.40% Shares Shorted/Prior 9.88M/7.56M Price 1.64
Gross Margin - Profit Margin - Avg. Volume 8,427,434 Target Price 14.14
Oper. Margin -780.65% Earnings Date Aug 4 Volume 14,772,505 Change -2.38%
Ardelyx, Inc. News
08/03/21 SHAREHOLDER ALERT: RLX ARDX ATVI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
08/03/21 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX
08/03/21 SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ardelyx Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 28, 2021 - ARDX
08/03/21 ROSEN, A RESPECTED AND LEADING LAW FIRM, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – ARDX
08/03/21 ARDX ALERT - Shareholder Rights Firm Labaton Sucharow is Investigating Ardelyx, Inc. (NASDAQ:ARDX) for Potential Securities Violations and Breach of Fiduciary Duty
08/03/21 SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ardelyx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
08/03/21 ARDX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Ardelyx, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm
08/03/21 ARDX FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ardelyx, Inc.
08/03/21 Investors with Substantial Losses Have Opportunity to Lead the Ardelyx Inc. Class Action Lawsuit - ARDX
08/02/21 ARDX INVESTOR ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline - ARDX
08/02/21 INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Ardelyx, Inc. (ARDX) Investors
08/02/21 SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ardelyx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
08/02/21 ARDX INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Ardelyx, Inc.
08/02/21 ARDX NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Ardelyx Inc. Class Action Lawsuit
08/02/21 EQUITY ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important Deadline – ARDX
08/02/21 ARDX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ardelyx, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm
07/30/21 ARDELYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ardelyx, Inc. and Encourages Investors to Contact the Firm
07/30/21 ARDX ALERT: Investors with Substantial Losses Have Opportunity to Lead the Ardelyx Inc. Class Action Lawsuit
07/30/21 Ardelyx, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase 3 clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program that is in Phase 2 clinical trial for the treatment of patients with hyperkalemia; and RDX020, a small molecule program for the treatment of metabolic acidosis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Fremont, California.

ARDX Chatroom

User Image jeremy0916 Posted - 20 minutes ago

$ARDX Well even on ARDX'es website they have had that they are looking for a partnership in the US for IBS-C... which that approval was a long time ago so must not have been very good bites... But now against the ropes I imagine they will take just about whatever they can get that is not a freebie haha.

User Image toddtaylor4544trtr Posted - 33 minutes ago

$ARDX Real price will come out soon,, watch out. 🚀 discord.io/LiveWinningAlert

User Image WallStreetOdds_ Posted - 54 minutes ago

$ARDX Out of the 749 other times ARDX was down 3.0% during a trading day, 50% of the time it traded higher by the market close 5 trading days later. #CoinFlip wallstreetodds.com

User Image Social_Idiot Posted - 1 hour ago

$PLX $ARDX Sanofi is acquiring Translate Bio. Legal documents were filed today. https://www.sec.gov/Archives/edgar/data/1693415/000119312521234062/d191890dex21.htm which states " Within the previous five years, neither the Company, any Subsidiary of the Company, any director or officer of the Company, nor, to the knowledge of the Company, any employee, representative, agent, consultant, or any other person (in each case, acting for or on behalf of the Company or a Subsidiary of the Company) has violated any provision of any Anti-Corruption Laws or any rules or regulations promulgated thereunder,.." Sanofi claiming in past 5 years, it's not been in violation of antin corruption laws. However wikipedia helps us with fact . https://fr.wikipedia.org/wiki/Sanofi

User Image erickbaldwin Posted - 3 hours ago

$ARDX Watch out best plays in stocks & options today👀 Congrats to all members who followed us on this great play,....,,, discord.io/AnotherWinningAlert

User Image Ltdcgg Posted - 4 hours ago

$ARDX Feast at $1.64, sell at $2. Rinse and repeat if winds blows it that way. Absolute agony for those who averaged in above $2.50 but lesson learnt, set your stop loss.

User Image Sanmeet0512 Posted - 4 hours ago

$FSR and $ARDX my two retirement stocks. Hoping to work just 3-4 more years.

User Image stocktowatch7 Posted - 5 hours ago

$ARDX, $IKT described at http://www.stocksequity.com/active-stocks/hair-raising-facts-to-know-ardelyx-inc-nasdaqardx-inhibikase-therapeutics-inc-nasdaqikt/

User Image terobau__ Posted - 5 hours ago

$ARDX Lmfao someone decided to bring the lawsuit cause the stock dropped hard and it's not going their way 😂 grow some balls 🤦‍♂️

User Image Waylon1 Posted - 6 hours ago

$ARDX

User Image ripDrip Posted - 6 hours ago

$ARDX 1.30’s iam your profit

User Image ritzponz Posted - 7 hours ago

$ARDX Added 3k shares more. Don’t care about lawsuit.

User Image cctranscripts Posted - 7 hours ago

SHAREHOLDER ALERT: RLX ARDX ATVI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines https://conferencecalltranscripts.com/summary/?id=265778&pr=true $ARDX

User Image demetrin Posted - 7 hours ago

$ARDX 32,62% SI…..

User Image TargetedPROFIT Posted - 7 hours ago

$ARDX There will be no damn lawsuit against the company. This shit happens to any business all the damn time. These are the equivalent of ambulance chasers. It will come to nothing. It never does.

User Image cctranscripts Posted - 8 hours ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX https://conferencecalltranscripts.com/summary/?id=265764&pr=true $ARDX

User Image fla Posted - 8 hours ago

$ARDX [15s. delayed]: Issued Press Release on August 03, 18:00:00: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of https://s.flashalert.me/U50C1V

User Image RRosco Posted - 8 hours ago

$ARDX Now that more bashers are showing up I will double my position this week. You bashers are almost as good as a chart sometimes.......

User Image Pacho_Unlimited Posted - 8 hours ago

$ARDX Just one PR....

User Image JBigDck Posted - 9 hours ago

$ARDX this stock won’t move until it’s FDA approved

User Image tradersgraphics Posted - 9 hours ago

$ARDX ARDX 2021-08-03 Options Analysis Video: https://www.youtube.com/watch?v=CINUS47jEcI

User Image mailman1961 Posted - 9 hours ago

$ARDX based on insider activity, the company insiders have aggressive 10b5 plans - which means they have planned sells established months ago when they thought this was going to be 9/10sh - assuming those are still in place, there is plenty of motivation to increase SP. Also, hopefully they tell us when they have submitted the briefing documents so we can estimate when the catalyst is - the Type A meeting is like a 3rd PDUFA for this company this year.

User Image Tooclutch4you Posted - 9 hours ago

$ARDX $RCON fear mongering 🥱 just gotta wait it out

User Image Carl0s_Danger Posted - 10 hours ago

$ARDX watching for when it drops below $1 so I can get in.

User Image ChartMill Posted - 10 hours ago

$ARDX: ROSEN, A RESPECTED AND LEADING LAW FIRM, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K ... https://www.chartmill.com/news/ARDX/globenews-2021-8-3-rosen-a-respected-and-leading-law-firm-encourages-ardelyx-inc-investors-with-losses-in-excess-of-100k-to-secure-counsel-before-important-deadline-ardx?utm_source=stocktwits&utm_medium=pressRelease&utm_content=ARDX&utm_campaign=social_tracking

User Image SweStonk Posted - 10 hours ago

$ARDX Take your losses and join $CCXI ChemoCentryx got an extension, review date 7 Oct but it might come sooner also!!! 80% of all extensions leaded to approval! But some that didn’t get approval got it a few months later! Avacopan is a game changer and prednisone “only treatment at the moment” have steroids in it! Which damage the patients with long term use! Avacopan are much healthier and gives a much better life standard for the patients! Before extension it traded at $50-$70 With approval this stock will be a multi runner with 400% gain

User Image jeremy0916 Posted - 10 hours ago

$ARDX The churn and volumes are likely tutes that are offloading shares just FYI. Counter capital gains and some cut stocks that go below certain dollar prices... should shake out in a few more weeks and then we can decide where to go from there.

User Image Huskersnsaints Posted - 10 hours ago

$ARDX this is one stock that has turned into a political nightmare for shareholders over $7 bucks stunning unwarranted drop with no bounce being held down by pure manipulation and big pharma corruption!!!! at $1.65 one of the best buy's out there!!!!

User Image XLR300 Posted - 10 hours ago

$ARDX in the screenshot below, it appears that when the high volume BUY happened the morning of 7/30, the institutional bears immediately responded to keep the price action in check... just my take on it.

User Image fla Posted - 10 hours ago

$ARDX [15s. delayed]: Issued Press Release on August 03, 15:45:00: ROSEN, A RESPECTED AND LEADING LAW FIRM, Encourages Ardelyx, Inc. Inves https://s.flashalert.me/iCL3wx

Analyst Ratings
Jefferies Hold Jul 21, 21
Wedbush Neutral Jul 20, 21
Piper Sandler Neutral Jul 20, 21
Wedbush Outperform Mar 23, 21
Cantor Fitzgerald Overweight Jan 6, 21
SVB Leerink Outperform Dec 11, 20
Citigroup Buy Feb 12, 20
Cowen & Co. Outperform Feb 10, 20
SVB Leerink Outperform Sep 24, 19
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own
GRAMMER ELIZABETH A See Remarks See Remarks Dec 15, 4:22 PM Option 2.32 42,000 97,440 113,527
GRAMMER ELIZABETH A See Remarks See Remarks Dec 15, 4:22 PM Sell 7.3 42,000 306,600 72,527